Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Odette M Smith

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Cancer Discovery|February 20, 2014
A small-molecule c-Rel inhibitor reduces alloactivation of T cells without compromising antitumor activityYusuke Shono, Andrea Z Tuckett, Samedy Ouk, et al.
Journal of the National Cancer Institute|May 14, 2010
Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growthOlaf Penack, Erik Henke, David Suh, et al.
Nature Medicine|January 9, 2018
Suppression of luteinizing hormone enhances HSC recovery after hematopoietic injuryEnrico Velardi, Jennifer J Tsai, Stefan Radtke, et al.
Blood|November 18, 2008
Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantationRobert R Jenq, Christopher G King, Christine Volk, et al.
The Journal of Clinical Investigation|December 4, 2009
The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host diseaseIl-Kang Na, Sydney X Lu, Nury L Yim, et al.
Nature Medicine|April 11, 2018
Corrigendum: Suppression of luteinizing hormone enhances HSC recovery after hematopoietic injuryEnrico Velardi, Jennifer J Tsai, Stefan Radtke, et al.
The Journal of Experimental Medicine|May 2, 2012
Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantationRobert R Jenq, Carles Ubeda, Ying Taur, et al.
Blood|November 2, 2018
Nrf2 regulates CD4<sup>+</sup> T cell-induced acute graft-versus-host disease in miceJennifer J Tsai, Enrico Velardi, Yusuke Shono, et al.
Nature Medicine|August 29, 2006
Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantationJohannes L Zakrzewski, Adam A Kochman, Sydney X Lu, et al.
The Journal of Clinical Investigation|May 17, 2013
Adoptively transferred TRAIL+ T cells suppress GVHD and augment antitumor activityArnab Ghosh, Yildirim Dogan, Maxim Moroz, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Cancer Discovery|February 20, 2014
A small-molecule c-Rel inhibitor reduces alloactivation of T cells without compromising antitumor activityYusuke Shono, Andrea Z Tuckett, Samedy Ouk, et al.
Journal of the National Cancer Institute|May 14, 2010
Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growthOlaf Penack, Erik Henke, David Suh, et al.
Nature Medicine|January 9, 2018
Suppression of luteinizing hormone enhances HSC recovery after hematopoietic injuryEnrico Velardi, Jennifer J Tsai, Stefan Radtke, et al.
Blood|November 18, 2008
Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantationRobert R Jenq, Christopher G King, Christine Volk, et al.
The Journal of Clinical Investigation|December 4, 2009
The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host diseaseIl-Kang Na, Sydney X Lu, Nury L Yim, et al.
Nature Medicine|April 11, 2018
Corrigendum: Suppression of luteinizing hormone enhances HSC recovery after hematopoietic injuryEnrico Velardi, Jennifer J Tsai, Stefan Radtke, et al.
The Journal of Experimental Medicine|May 2, 2012
Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantationRobert R Jenq, Carles Ubeda, Ying Taur, et al.
Blood|November 2, 2018
Nrf2 regulates CD4<sup>+</sup> T cell-induced acute graft-versus-host disease in miceJennifer J Tsai, Enrico Velardi, Yusuke Shono, et al.
Nature Medicine|August 29, 2006
Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantationJohannes L Zakrzewski, Adam A Kochman, Sydney X Lu, et al.
The Journal of Clinical Investigation|May 17, 2013
Adoptively transferred TRAIL+ T cells suppress GVHD and augment antitumor activityArnab Ghosh, Yildirim Dogan, Maxim Moroz, et al.
Pageof 4